Pyrazole-Thiazole Hybrids: Synthesis and Biological Evaluation against Trypanosoma cruzi and Mycobacterium tuberculosis
Year: 2026
Type: article
Abstract: High Resolution Image Download MS PowerPoint Slide Pyrazole–thiazole hybrids 1(a–k) were synthesized and fully characterized to investigate their biological activities against Trypanosoma cruzi and Mycobacterium tuberculosis . Physicochemical profiling confirmed favorable drug-like properties across the series. Biological assays identified compound 1g (3-F) as the most active against T. cruzi, with IC 50 values of 11.66 μM (SI > 42.8) in trypomastigotes and 26.83 μM (SI > 18.9) in amastigotes. Compound 1h (4-Br) displayed significant antimycobacterial activity, with a MIC of 32.28 μM against the H37Rv strain. In silico analyses suggested preferential stabilization of halogenated derivatives through hydrophobic and π-driven interactions in structurally related enzymatic pockets, used here as an exploratory model. Taken together, these findings demonstrate that halogen substitution strongly modulates affinity and biological performance, supporting pyrazole–thiazole hybrids as promising scaffolds for further optimization against neglected-parasite pathogens. Future studies expanding halogen patterns and probing alternative binding pockets may improve potency and target selectivity across this chemical space.
Source: ACS Omega
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $1,935
Funders: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Fundação Oswaldo Cruz, Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica
Awards: G119622891, G1324651861, G1577541708, G1840770272, G22113365, G2311368543, G2547851073, G268011837, G2892268805, G3647083920, G3690646728, G3733163740, G4156952298, G5937921114, G6305449948, SÍNTESE, CARACTERIZAÇÃO FÍSICO-QUÍMICA E TESTES DE ATIVIDADE ANTILEISHMANIA DE NOVOS DERIVADOS AMIDÍNICOS, G7254453866, Synthesis and characterization of antimicrobial peptide ""B1CTcu5"" analogs encapsulated in colon-specific microparticles and in vitro an in vivo studies against Mycobacterium tuberculosis, G7839426479, G8722446023, G888774268, G89104316
OpenAlex ID: W7146989701
